Bringing new drugs onto the market can take years, so any delay will result in loss of income. Tremendous losses are sustained, if at the end of this long process, the competition then takes off with the innovation. The registration procedure, however, can be speeded up by the efficient transfer of technology between R&D, on the one hand, and production, on the other hand.